Background: Periods of immobilization are often associated with pathologies and/or aging. These periods of disuse muscle atrophy could worsen the pathology or elderly frailty. Exercise, the best way to recover muscle mass, is not always applicable.
INTRODUCTION
Muscle atrophy occurs in the presence of inactivity, sarcopenia and various neuromuscular diseases leading to a marked decrease in physical activity and the inevitable progression of muscle wasting [1] .
Skeletal muscle possesses a highly plastic potential to cope with the demands of various environmental conditions. It is composed of a variety of proteins and is regulated by the balance between protein synthesis and degradation. However, marked increase in protein degradation and decrease in protein synthesis will result in muscle atrophy [1] .
There has been increasing interest in the development of effective agents that can be safely used to promote anabolism in the clinical setting for patients with chronic wasting conditions as well as in the prevention and treatment of frailty associated with loss of muscle tissue in aging (sarcopenia) [2] .
Satellite cells have been shown to possess a critical role in skeletal muscle regeneration, during which satellite cells are activated, proliferate and differentiate to support regeneration and new myofiber formation [3] .
Apart from often strenuous and high intensity exercise prescriptions that may not always be well tolerated especially in old age, alternative protocols could be a reasonable and feasible approach for reduction of muscle wasting in prolonged inactivity in bed rest, critical illness or nerve damage. The emphasis is on the therapies that can increase muscle mass and improve functional outcomes that will ultimately lead to improvement in the quality of life for affected patients [4] .
Endogenous testosterone production gradually decreases with advancing age in men. Anabolic therapies are currently widely used to promote retention and gain of muscle mass and strength in hypogonadal old men [5] .
Oxandrolone is the only anabolic androgenic steroid that is FDA approved for treatment of muscle wasting. It increases protein synthesis and accelerates activation of satellite cells [6] .
Essential amino acids (EAA), especially branched chain amino acids (BCAA), have a particular role in the regulation of muscle protein synthesis. Many studies have demonstrated that BCAA stimulate muscle protein synthesis, facilitate the initiation of mRNA translation and suppress protein degradation .Whey protein is a rich source of BCAA and is thought to have beneficial effects on skeletal muscle turnover [7] .
MATERIAL AND METHODS

A-Material (I) Drugs used
1. Anesthesia: a mixture of Ketamine (60 mg/kg) (Pfizer Pharmaceuticals, Egypt) and Xylazine (10 mg/kg) (Adura Pharmaceuticals, Egypt) was administered intraperitonealy [8] .
Oxandrolone:
(trade name Anavar) in the form of tablets 10 mg each (Meditech Human Pharmaceuticals, Ingoldheim, Germany). Each tablet was crushed and dissolved in 5 ml sesame oil. Oxandrolone human dose 0.2 mg/kg [2] was converted to rat dose 1.23 mg/kg [9] .
Whey protein:
100% pure whey protein isolate in the form of powder (OLIMP sport nutrition, OLIMP LABORATORIES, EU) was used. A serving of 25g was dissolved in 20 ml water. Whey protein human dose 1.5 gm/kg [10] was converted to rat dose 9.25 gm/kg [9] .
(II) Animals
Twenty four aged male albino rats 18-20 months were used in this study, their weights ranging from 250-350 gm each with serum total testosterone level not exceeding 3.18±0.14 ng/ml [11] . The study was conducted at the Animal House of Kasr-Al Aini School of Medicine, according to the guidelines for the care and use of laboratory animals after the approval of the ethical committee. Each subgroup was housed separately in standard stainless-steel cages and each animal in group II was housed separately in smaller stainless-steel cages under standard environmental conditions with free access to a standard chow and water (ad libitum).
Experimental Design
Animals were randomly divided into the following 3 groups:
Rats received anesthesia in the form of a mixture of ketamine (60 mg/kg) and xylazine (10 mg/kg) by intra peritoneal injection [8] .
Then rats were further subdivided into the following subgroups:
Rats were sacrificed after 2 weeks.
-Subgroup Ib: (n=2) After 2 weeks, rats received 0.3 ml sesame oil [the solvent of oxandrolone] daily by oral route for 4 weeks. Rats were sacrificed after 6 weeks.
-Subgroup Ic: (n=2)
Rats were sacrificed after 6 weeks.
• Group II (Disuse Atrophy Group): (n=6)
Hind Limb Suspension (HLS) [12] was done to induce atrophy in right gastrocnemius muscle and rats were sacrificed after 2 weeks to confirm atrophy [13] .
• Group III (treated Group): (n=12)
Rats were further equally subdivided into the following subgroups:
Rats were subjected to HLS as in group II, left untreated for 2 weeks then received oxandrolone in subgroup IIIa (n=6) and whey protein in subgroup IIIb (n=6) orally daily through gastric gavage for 4 weeks then rats were sacrificed after 6 weeks from HLS.
B-Methods
I-Disuse muscle atrophy
Animals were anesthetized then were subjected to Hind limb suspension (HLS). Stainless steel multifilament electrode insulated needle was inserted along the proximal part of the tail and then attached to the cover of the cage to provide free movement of the rat around the cage. The forelimbs remained in contact with the cage floor, which allowed the animals to move and obtain food and water freely. The exposed tail was monitored to ensure that it remained pink, indicating that the blood flow to the tail was not compromised. Each animal was suspended in a separate cage to ensure the competence of the procedure and prevent rats from cutting off the tails of each other from the cover of the cage. After reloading rats were put in small cages to limit their mobility [12] .
II-Biochemical Investigations: Serum total Testosterone
Blood samples were collected from the tail veins of rats before the start of the experiment and before time of sacrifaction in induced atrophy group and oxandrolone treated subgroup [14] . Rats with serum total testosterone level above 3.18±0.14 ng/ml at the start of the experiment were excluded. Blood samples were also collected from young adult (8-10 months) rats and serum total testosterone was measured (6.07±1.23 ng/ml).
III-Total Muscle Protein Content
Total muscle protein content was measured as a test for estimating muscle atrophy in addition to increased protein synthesis after treatment. Total muscle proteins were extracted by treating 100-200 mg of gastrocnemius muscle tissue with HCL and PBS then muscle homogenate was centrifuged at 12000 rpm. The supernatant was used for detection of total protein content using a Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA) [15] .
IV-Light Microscopic Examination
Mid-belly portions of right gastrocnemius muscle specimens were obtained and paraffin sections were subjected to the following stains:
1-Histological Staining
a-Hematoxylin & Eosin (H&E) stain [16] for histological evaluation.
b-Periodic Acid Schiff (PAS) stain [17] was used to differentiate between types of muscle fibers -Type I (little glycogen content) appear lightly stained -Type II (abundant glycogen content) appear darkly stained 2-Immunohistochemical staining: using the avidinbiotin peroxidase complex technique [18] , for detection of: Myogenin immunopositive cells. Myogenin is a musclespecific basic-helix-loop-helix (bHLH) transcription factor involved in the coordination of skeletal muscle development or myogenesis and repair. Myogenin is a member of the MyoD family of transcription factors [19] .
VI-Morphometric Study
Data were obtained using "Leica Qwin 500 C" image analyzer computer system Ltd. (Cambridge, England). For each group, five slides of five different specimens were examined. From each slide, ten non-overlapping fields were measured in a standard measuring frame. The following parameters were measured:
1. The mean number of type I (light) and type II (dark) fibers in PAS stained sections (x100 magnification).
2.
The mean CSA of type I (light) and type II (dark) fibers of gastrocnemius muscle in PAS stained sections of the studied groups (x100 magnification).
3. The mean number of immunopostive myogenin stained cells in myogenin stained sections in different fields (x200 magnification).
VII-Statistical Analysis
The measurements obtained were analyzed using SPSS software version 16 (SPSS, Chicago, IL). Comparison between different groups was made using analysis of variance (ANOVA) followed by post hoc Tukey test. The results were expressed as means ± standard deviation (SD). The differences were considered statistically significant when "p value" was <0.05 [20] .
RESULTS
No mortality was recorded in the present study. (I) Biochemical Investigations The mean serum total Testosterone level in selected studied groups (Histogram 1):
The mean serum total testosterone level of aged rat (18-20 months) was 3.18±0.14 ng/ml. A significant increase in the mean serum total testosterone was reported in subgroup IIIa (oxandrolone treated) (4.01±1.27 ng/ml) when compared to group II (disuse) (3.22±0.55ng/ml). Among all oxandrolone treated rats, the mean serum testosterone level never went out of the normal level of young adult (8-10 months) rat (6.07±1.23 ng/ml) which was also measured in this study.
(II) The mean total muscle protein content of right gastrocnemius muscle (Histogram 2):
A significant decrease in the total protein content of gastrocnemius muscle was reported in group II (disuse) (45.1±1.23) as compared to the control group (85.9±0.71). Subgroup IIIa (oxandrolone treated) (74.8±1.73) showed a significant increase in the total protein content as compared to group II (disuse) and subgroup IIIb (whey protein treated) (71.4±2.79). Meanwhile, subgroup IIIb showed a significant increase in this value as compared to group II.
(III) Histological Results
(a) Hematoxylin and Eosin Stained Sections (Fig.1)
Light microscopic examination of transverse sections of the control group I showed normal organization of skeletal muscle bundles. Each bundle consisted of a group of muscle fibers surrounded by C.T. perimysium. Muscle fibers appeared polyhedral with peripherally located oval nuclei and acidophilic sarcoplasm separated by narrow C.T. endomysium. Group II (disuse atrophy) showed myofiber size and shape variation, rounded atrophic fibers and some angulated atrophic fibers with small diameter. Apparent widening of spaces inbetween muscle fibers was noted. Some myofibers showed crowded nuclei (Nuclear clump). Dilated blood vessels were seen within the muscle bundles.
Subgroup IIIa (oxandrolone treated) showed muscle fibers with apparent large diameter and multiple peripheral nuclei, some nuclei appeared rounded and vesicular. Narrow C.T. endomysium was observed between muscle fibers as well as some blood vessels. Subgroup IIIb (whey protein treated) showed muscle fibers with apparent large diameter and narrow C.T. endomysium inbetween. Muscle bundles were surrounded by wide C.T. perimysium. Muscle fibers exhibited large number of peripheral nuclei while others showed centrally located ones. Elongated multinucleated fibers (myotubes) were present.
(b) Periodic Acid Schiff's Stained Sections (Fig.2)
Transverse sections of control group I showed mild PAS positive reaction in some fibers (type I muscle fibers) and dense PAS positive reaction in others (type II muscle fibers). Group II (disuse atrophy) showed dense PAS positive reaction in most fibers (type II) and mild PAS positive reaction in some fibers (type I). Subgroup IIIa (oxandrolone treated) showed mild PAS positive reaction (type I) in most fibers while few showed dense PAS positive reaction (type II). Subgroup IIIb (whey protein treated) showed dense PAS positive reaction in some fibers (type II) while others showed mild PAS positive reaction (type I).
(IV) Immunostaining with Myogenin (Fig.3) Transverse sections of control group I showed few immunopositive nuclei close to sarcolemma of muscle fibers (differentiated satellite cells). Group II (disuse atrophy) showed negative immune reaction for myogenin. Subgroup IIIa (oxandrolone treated) showed multiple immunopositive nuclei close to sarcolemma of muscle fibers. While subgroup IIIb (whey protein treated) showed some immunopositive nuclei close to sarcolemma of muscle fibers.
(V) Quantitative Morphometric Results
(a) Mean number of light (type I)and dark (type II) fibers in PAS stained sections (Histogram 3)
The mean numberof light (type I) fibers of the control group was (77.8±2.35). This value showed a significant decrease in disuse atrophy group when compared to the control group, being (14.7±2.83). There was a significant increase in subgroup IIIa (oxandrolone treated) (107.2±1.55) when compared to the control group, the disuse group (group II) and also the whey protein treated subgroup (subgroup IIIb) (75.4±1.07). While the mean number of dark (type II) fibers of the the control group (I) was (72.2±2.35). A significant increase in this value was reported in disuse atrophy group being (135.3±2.83), as compared to the control group. Value reported for subgroup IIIa (oxandrolone treated) (42.8±1.55) represented a significant decrease when compared to the control group, the disuse group (group II) and also the whey protein treated subgroup (subgroup IIIb) (74.6±1.07).
(b) Mean CSA of light (type I) and dark (type II) fibers of in PAS stained sections (Histogram 4)
The mean CSA of light (type I) fibers of the control group was (157.3±10.68). A significant decrease in this value was reported in group (II) being (90.3±15.02), as compared to the control group. A significant increase in the mean area of light (type I) fibers was noted in subgroup IIIa, being (197.7±51.65), as compared to the control group, group II and subgroup IIIb (145.7±12.68). While the mean CSA of dark (type II) fibers of the control group was (156.7±10.69). A significant decrease in this value was reported in group (II) being (88.1±14.15), as compared to the control group. A significant increase in the mean area of dark (type II) fibers was noted in subgroup IIIa (157.5±15.77) as compared to group II. However, this value was not statistically significant when compared to the control group.
(c) Mean number of immunopostive nuclei (differentiated satellite cells) in Myogenin stained sections (Histogram 5)
The mean number of immunopositive nuclei of the control group was (1.2±0.79). The value reported for disuse (group II) was non-significant when compared to the control, being (0.5±0.03). The mean number of immunopositive nuclei of subgroup IIIa (17.2±1.23) showed a significant increase as compared to the control group, group II and subgroup IIIb (6.9±0.88). However, subgroup IIIb represented a significant increase in this value when compared to the control group and the disuse group. 
DISCUSSION
Various approaches such as resistance training, nutritional supplementation, hormonal and pharmacological treatment have been attempted to inhibit muscle atrophy particularly in sarcopenia [1] . Muscle size is dependent on the number and volume of muscle fibers, which is directly related to satellite cells. These quiescent and undifferentiated cells are activated from the quiescent state upon appropriate stimulatory signals and undergo active proliferation and myogenic differentiation [21] .
Hind limb suspension, the most commonly used animal model to experimentally induce muscle atrophy in rats [12] was used in the present study. Rats were put in small cages after unloading to limit their mobility. Gastrocnemius musle was the muscle of choice as it provides a reasonable amount of tissue to be examined, contains both fast and slow twitch muscle fibers and it's one of the antigravity muscles [22] .
The FDA approved drug, oxandrolone was used In the present study, as it is an androgenic steroid with high anabolic to androgenic potency, less expensive and can be administered orally as well as less hepatotoxic compared to other androgens [23] . Moreover, androgen administration can increase satellite cell number in animals and humans in a dose dependent manner [24] .
Healthy older men provide a unique model to assess the mechanism by which testosterone promotes muscle anabolism by increasing testosterone while still maintaining serum values within the normal range. So, in the present study, all rats entered the study with average concentrations of circulating total testosterone in the lower half of normal range (3.18±0.14 ng/ml) and never went out, in all groups treated with oxandrolone [25] .
Whey protein was used in the present study as it is a rich source of BCAA and is thought to have beneficial effects on skeletal muscle turnover. Ingestion of whey protein strongly stimulates muscle protein synthesis in a dose-dependent manner as they facilitate the initiation of mRNA translation [7] . Moreover, delivery and uptake of glucose and essential amino acids may also influence satellite cell activity [26] .
The total protein content, as an outstanding measure of atrophy and protein synthesis, was measured in all groups. The values reported for the disuse atrophy group were significantly less than that of control group which indicates protein degradation. Oxandrolone treated subgroup was significantly higher than disuse atrophy group and whey protein treated subgroup. This might be due to the anabolic effect of oxandrolone and its ability to increase protein synthesis. Camerino et al. (2015) [15] reported that hindlimb unloading induced a significant drop of protein content of muscle with respect to control, however total muscle protein content was preserved by nandrolone treatment. Also whey protein treated subgroup showed a significant increase in the total protein content of gastrocnemius muscle as compared to disuse atrophy group but was significantly less than oxandrolone treated one. This indicates that whey protein increased the protein synthesis or has anticatabolic effects [4] .
Histological examination of H&E stained sections of disuse atrophy group showed marked myofiber size variation. Some atrophic fibers appeared rounded while others were angulated. Similar results were reported by Bodine (2013) [27] . Crowded nuclei (Nuclear clump) were also noted in this group. This could be explained by that, in atrophy, some myofibers become depleted of myofibrillar apparati and might become severely atrophic to the point that there was only a nuclear clump left [28] .
Muscle fibers with large diameter, as confirmed by quantitative morphometric results for CSA in oxandrolone treated subgroup, was found in the present study. This anabolic effect was likely mediated by binding to the androgen receptor (AR) that allowed the activation of specific DNA nucleotide sequences in the nucleus which influenced the transcriptional activity of specific proanabolic genes [15] . Large number of rounded vesicular nuclei close to sarcolemma, confirmed by myogenin immunostaining to be activated satellite cells nuclei, were noted. Some of these nuclei appeared in the C.T. endomysium between muscle fibers which indicated that it is possible that migrating satellite cells also differentiate and help form new fibers rather than fuse with parent fiber. Androgen administration also increases satellite cell number and androgen receptor levels in animals and humans in a dose-dependent manner [24] .
Histological examination of H&E stained sections of whey protein treated subgroup showed muscle fibers with large diameter, as confirmed by quantitative morphometric results for CSA. Similar findings were reported by Bunn (2012) [29] . Some muscle fibers with central nuclei were also found indicating regenerating muscle fibers [30] . In vitro satellite cell (SC) proliferation is increased with administration of essential amino acids (EAAs), possibly mediated through an increased activation of the mammalian target of rapamycin (mTOR) kinase complex and subsequent increased mRNA translation [31] .
Elongated multinucleated muscle fibers (myotubes)
were also noted in subgroup IIIb. This might be an attempt of myotube regeneration stimulated by whey protein.
During regeneration, several myoblasts fuse to form myotubes which may serve as a scaffold and eventually increase in size and nuclei number by fusing with additional myoblasts eventually forming a multinucleated contractile muscle fiber [32] .
PAS stained sections of disuse atrophy group showed a significant increase of darkly stained type II muscle fibers as compared to the control. Similar findings were reported by Brooks and Myburgh (2014) [33] .This might be due to reduced capacity for fat oxidation in skeletal muscle in cases of disuse [34] . A significant decrease in the mean CSA of both type I and type II muscle fibers, with slightly greater loss of CSA of type II fibers, in disuse atrophy group as compared to the control was noted. The decline in type II muscle fiber size is reported in some studies to be accompanied by an age-related reduction in type II muscle fiber satellite cell content and function [35] .
The significant increase in the number and CSA of type I in oxandrolone treated subgroup when compared to the disuse atrophy group was also reported by Ustunel et al. (2003) [36] who stated that it might be due to an increase in bifurcation of myofibrils, an increase in the number and diameter of units resembling T tubules, an increase in pinocytic vesicles and an increase in ribosomal content of type I fibers. This might also be due to different number of androgen receptors in different fiber types.
Whey protein treated subgroup showed more type I muscle fibers than type II with a significant increase of CSA of both types as compared to disuse atrophy group. This goes with Cribb et al. (2007) [37] who found no changes in fiber type proportions in groups treated by whey protein across time and reported that an increase in contractile protein content, induced by whey protein, is thought to be an important stimulus that results in an increase in muscle fiber CSA across all fiber types. Comparing morphometric results, oxandrolone treated subgroup in the present work showed a significant increase in the number and CSA of type I fibers than whey protein treated subgroup.
Anti-myogenin immunostaining of the nuclei of muscle fibers in the present study was negative in disuse atrophy group which was also reported in human studies of 14 days immobilization [38] . A significant increase in the number of immunopositive nuclei (differentiated satellite cells) was observed in the subgroup treated by oxandrolone as compared to the control and disuse atrophy group. Testosterone induced increase in muscle mass is associated with a proportionate increase in the number of satellite cells and myonuclei [39] . In whey protein treated subgroup, the number of immunopositive nuclei showed a significant increase when compared to the control group and the disuse atrophy group. Farup et al. (2014) [3] reported similar results and mentioned that, whey protein accelerated the expansion of the satellite cell pool, when compared with placebo supplement. However, the number of immunopositive nuclei of whey protein treated subgroup showed significant decrease when compared to the oxandrolone treated subgroup, suggesting greater efficacy of oxandrolone versus whey protein in activation of satellite cells. CONCLUSION Oxandrolone proved to have better therapeutic potential than whey protein in ameliorating disuse muscle atrophy in old aged male rats with low testosterone level and mobility limitation by stimulating and enhancing satellite cells differentiation.
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